{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:34:06Z","timestamp":1787726046183,"version":"build-2784847793"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T00:00:00Z","timestamp":1355788800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1038\/nrneurol.2012.258","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T11:37:57Z","timestamp":1355830677000},"page":"98-105","source":"Crossref","is-referenced-by-count":38,"title":["Immunotherapy in prion disease"],"prefix":"10.1038","volume":"9","author":[{"given":"Yvonne","family":"Roettger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansheng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Dodel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Philipp","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,18]]},"reference":[{"key":"BFnrneurol2012258_CR1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1750-3639.1998.tb00171.x","volume":"8","author":"SB Prusiner","year":"1998","unstructured":"Prusiner, S. B. The prion diseases. Brain Pathol. 8, 499\u2013513 (1998).","journal-title":"Brain Pathol."},{"key":"BFnrneurol2012258_CR2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0092-8674(83)90207-6","volume":"35","author":"MP McKinley","year":"1983","unstructured":"McKinley, M. P., Bolton, D. C. & Prusiner, S. B. A protease-resistant protein is a structural component of the scrapie prion. Cell 35, 57\u201362 (1983).","journal-title":"Cell"},{"key":"BFnrneurol2012258_CR3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","volume":"24","author":"J Collinge","year":"2001","unstructured":"Collinge, J. Prion diseases of humans and animals: their causes and molecular basis. Annu. Rev. Neurosci. 24, 519\u2013550 (2001).","journal-title":"Annu. Rev. Neurosci."},{"key":"BFnrneurol2012258_CR4","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/226462a0","volume":"226","author":"H Fraser","year":"1970","unstructured":"Fraser, H. & Dickinson, A. G. Pathogenesis of scrapie in the mouse: the role of the spleen. Nature 226, 462\u2013463 (1970).","journal-title":"Nature"},{"issue":"Suppl. 5","key":"BFnrneurol2012258_CR5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2516.2007.01572.x","volume":"13","author":"P Brown","year":"2007","unstructured":"Brown, P. Creutzfeldt\u2013Jakob disease: reflections on the risk from blood product therapy. Haemophilia 13 (Suppl. 5), 33\u201340 (2007).","journal-title":"Haemophilia"},{"key":"BFnrneurol2012258_CR6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/jcp.2003.012278","volume":"57","author":"DA Hilton","year":"2004","unstructured":"Hilton, D. A. et al. Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt\u2013Jakob disease. J. Clin. Pathol. 57, 300\u2013302 (2004).","journal-title":"J. Clin. Pathol."},{"key":"BFnrneurol2012258_CR7","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMoa030351","volume":"349","author":"M Glatzel","year":"2003","unstructured":"Glatzel, M., Abela, E., Maissen, M. & Aguzzi, A. Extraneural pathologic prion protein in sporadic Creutzfeldt\u2013Jakob disease. N. Engl. J. Med. 349, 1812\u20131820 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2012258_CR8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2174\/1871526510909010092","volume":"9","author":"I Zerr","year":"2009","unstructured":"Zerr, I. Therapeutic trials in human transmissible spongiform encephalopathies: recent advances and problems to address. Infect. Disord. Drug Targets 9, 92\u201399 (2009).","journal-title":"Infect. Disord. Drug Targets"},{"key":"BFnrneurol2012258_CR9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/bmb\/66.1.281","volume":"66","author":"D Dormont","year":"2003","unstructured":"Dormont, D. Approaches to prophylaxis and therapy. Br. Med. Bull. 66, 281\u2013292 (2003).","journal-title":"Br. Med. Bull."},{"key":"BFnrneurol2012258_CR10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.neuro.31.060407.125529","volume":"31","author":"DL Brody","year":"2008","unstructured":"Brody, D. L. & Holtzman, D. M. Active and passive immunotherapy for neurodegenerative disorders. Annu. Rev. Neurosci. 31, 175\u2013193 (2008).","journal-title":"Annu. Rev. Neurosci."},{"key":"BFnrneurol2012258_CR11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0092-8674(85)90333-2","volume":"40","author":"B Oesch","year":"1985","unstructured":"Oesch, B. et al. A cellular gene encodes scrapie PrP 27\u201330 protein. Cell 40, 735\u2013746 (1985).","journal-title":"Cell"},{"key":"BFnrneurol2012258_CR12","first-page":"1","volume":"122","author":"HA Kretzschmar","year":"1986","unstructured":"Kretzschmar, H. A., Prusiner, S. B., Stowring, L. E. & DeArmond, S. J. Scrapie prion proteins are synthesized in neurons. Am. J. Pathol. 122, 1\u20135 (1986).","journal-title":"Am. J. Pathol."},{"key":"BFnrneurol2012258_CR13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/CMR.12.3.429","volume":"12","author":"DA Harris","year":"1999","unstructured":"Harris, D. A. Cellular biology of prion diseases. Clin. Microbiol. Rev. 12, 429\u2013444 (1999).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFnrneurol2012258_CR14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/356577a0","volume":"356","author":"H Bueler","year":"1992","unstructured":"Bueler, H. et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577\u2013582 (1992).","journal-title":"Nature"},{"key":"BFnrneurol2012258_CR15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/380639a0","volume":"380","author":"I Tobler","year":"1996","unstructured":"Tobler, I. et al. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 380, 639\u2013642 (1996).","journal-title":"Nature"},{"key":"BFnrneurol2012258_CR16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0006-8993(97)00087-5","volume":"755","author":"SB Colling","year":"1997","unstructured":"Colling, S. B., Khana, M., Collinge, J. & Jefferys, J. G. Mossy fibre reorganization in the hippocampus of prion protein null mice. Brain Res. 755, 28\u201335 (1997).","journal-title":"Brain Res."},{"key":"BFnrneurol2012258_CR17","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1460-9568.1994.tb01003.x","volume":"6","author":"G Forloni","year":"1994","unstructured":"Forloni, G. et al. A neurotoxic prion protein fragment induces rat astroglial proliferation and hypertrophy. Eur. J. Neurosci. 6, 1415\u20131422 (1994).","journal-title":"Eur. J. Neurosci."},{"key":"BFnrneurol2012258_CR18","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1097\/00001756-199511270-00015","volume":"6","author":"SA Whatley","year":"1995","unstructured":"Whatley, S. A. et al. Regulation of intracellular free calcium levels by the cellular prion protein. Neuroreport 6, 2333\u20132337 (1995).","journal-title":"Neuroreport"},{"key":"BFnrneurol2012258_CR19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/exnr.1997.6505","volume":"146","author":"DR Brown","year":"1997","unstructured":"Brown, D. R., Schulz-Schaeffer, W. J., Schmidt, B. & Kretzschmar, H. A. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp. Neurol. 146, 104\u2013112 (1997).","journal-title":"Exp. Neurol."},{"key":"BFnrneurol2012258_CR20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/(SICI)1098-1136(19990201)25:3<282::AID-GLIA8>3.0.CO;2-N","volume":"25","author":"DR Brown","year":"1999","unstructured":"Brown, D. R. & Mohn, C. M. Astrocytic glutamate uptake and prion protein expression. Glia 25, 282\u2013292 (1999).","journal-title":"Glia"},{"key":"BFnrneurol2012258_CR21","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1126\/science.289.5486.1925","volume":"289","author":"S Mouillet-Richard","year":"2000","unstructured":"Mouillet-Richard, S. et al. Signal transduction through prion protein. Science 289, 1925\u20131928 (2000).","journal-title":"Science"},{"key":"BFnrneurol2012258_CR22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neulet.2004.09.030","volume":"372","author":"J Weise","year":"2004","unstructured":"Weise, J. et al. Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity. Neurosci. Lett. 372, 146\u2013150 (2004).","journal-title":"Neurosci. Lett."},{"key":"BFnrneurol2012258_CR23","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/01.STR.0000217262.03192.d4","volume":"37","author":"J Weise","year":"2006","unstructured":"Weise, J. et al. Deletion of cellular prion protein results in reduced Akt activation, enhanced postischemic caspase-3 activation, and exacerbation of ischemic brain injury. Stroke 37, 1296\u20131300 (2006).","journal-title":"Stroke"},{"key":"BFnrneurol2012258_CR24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-3-7091-0651-8_64","volume":"86","author":"S Hoshino","year":"2003","unstructured":"Hoshino, S. et al. Prions prevent brain damage after experimental brain injury: a preliminary report. Acta Neurochir. Suppl. 86, 297\u2013299 (2003).","journal-title":"Acta Neurochir. Suppl."},{"key":"BFnrneurol2012258_CR25","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1006\/jmbi.2000.5183","volume":"314","author":"G Schmitt-Ulms","year":"2001","unstructured":"Schmitt-Ulms, G. et al. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J. Mol. Biol. 314, 1209\u20131225 (2001).","journal-title":"J. Mol. Biol."},{"key":"BFnrneurol2012258_CR26","doi-asserted-by":"crossref","first-page":"44604","DOI":"10.1074\/jbc.M103289200","volume":"276","author":"C Spielhaupter","year":"2001","unstructured":"Spielhaupter, C. & Schatzl, H. M. PrPC directly interacts with proteins involved in signaling pathways. J. Biol. Chem. 276, 44604\u201344612 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol2012258_CR27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0169-328X(95)00323-K","volume":"37","author":"C Kurschner","year":"1996","unstructured":"Kurschner, C. & Morgan, J. I. Analysis of interaction sites in homo- and heteromeric complexes containing Bcl-2 family members and the cellular prion protein. Brain Res. Mol. Brain Res. 37, 249\u2013258 (1996).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"BFnrneurol2012258_CR28","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1093\/emboj\/cdf324","volume":"21","author":"LB Chiarini","year":"2002","unstructured":"Chiarini, L. B. et al. Cellular prion protein transduces neuroprotective signals. EMBO J. 21, 3317\u20133326 (2002).","journal-title":"EMBO J."},{"key":"BFnrneurol2012258_CR29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1044-7431(02)00014-3","volume":"22","author":"S Chen","year":"2003","unstructured":"Chen, S., Mange, A., Dong, L., Lehmann, S. & Schachner, M. Prion protein as trans-interacting partner for neurons is involved in neurite outgrowth and neuronal survival. Mol. Cell. Neurosci. 22, 227\u2013233 (2003).","journal-title":"Mol. Cell. Neurosci."},{"key":"BFnrneurol2012258_CR30","doi-asserted-by":"crossref","first-page":"11330","DOI":"10.1523\/JNEUROSCI.2313-05.2005","volume":"25","author":"MH Lopes","year":"2005","unstructured":"Lopes, M. H. et al. Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways. J. Neurosci. 25, 11330\u201311339 (2005).","journal-title":"J. Neurosci."},{"key":"BFnrneurol2012258_CR31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbrc.2005.04.099","volume":"332","author":"N Vassallo","year":"2005","unstructured":"Vassallo, N. et al. Activation of phosphatidylinositol 3-kinase by cellular prion protein and its role in cell survival. Biochem Biophys. Res. Commun. 332, 75\u201382 (2005).","journal-title":"Biochem Biophys. Res. Commun."},{"key":"BFnrneurol2012258_CR32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.pathol.1.110304.100113","volume":"1","author":"DM Skovronsky","year":"2006","unstructured":"Skovronsky, D. M., Lee, V. M. & Trojanowski, J. Q. Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu. Rev. Pathol. 1, 151\u2013170 (2006).","journal-title":"Annu. Rev. Pathol."},{"key":"BFnrneurol2012258_CR33","doi-asserted-by":"crossref","first-page":"11062","DOI":"10.1073\/pnas.0609621104","volume":"104","author":"ET Parkin","year":"2007","unstructured":"Parkin, E. T. et al. Cellular prion protein regulates \u03b2-secretase cleavage of the Alzheimer's amyloid precursor protein. Proc. Natl Acad. Sci. USA 104, 11062\u201311067 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2012258_CR34","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/4571090a","volume":"457","author":"M Cisse","year":"2009","unstructured":"Cisse, M. & Mucke, L. Alzheimer's disease: a prion protein connection. Nature 457, 1090\u20131091 (2009).","journal-title":"Nature"},{"key":"BFnrneurol2012258_CR35","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4161\/pri.3.4.9980","volume":"3","author":"KA Kellett","year":"2009","unstructured":"Kellett, K. A. & Hooper, N. M. Prion protein and Alzheimer disease. Prion 3, 190\u2013194 (2009).","journal-title":"Prion"},{"key":"BFnrneurol2012258_CR36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.parkreldis.2008.03.003","volume":"15","author":"V Wang","year":"2009","unstructured":"Wang, V., Chuang, T. C., Soong, B. W., Shan, D. E. & Kao, M. C. Octarepeat changes of prion protein in Parkinson's disease. Parkinsonism Relat. Disord. 15, 53\u201358 (2009).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFnrneurol2012258_CR37","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/nm0901-976","volume":"7","author":"FL Heppner","year":"2001","unstructured":"Heppner, F. L. et al. Transepithelial prion transport by M cells. Nat. Med. 7, 976\u2013977 (2001).","journal-title":"Nat. Med."},{"key":"BFnrneurol2012258_CR38","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri1437","volume":"4","author":"A Aguzzi","year":"2004","unstructured":"Aguzzi, A. & Sigurdson, C. J. Antiprion immunotherapy: to suppress or to stimulate? Nat. Rev. Immunol. 4, 725\u2013736 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrneurol2012258_CR39","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1089\/vim.2004.17.334","volume":"17","author":"N Daude","year":"2004","unstructured":"Daude, N. Prion diseases and the spleen. Viral Immunol. 17, 334\u2013349 (2004).","journal-title":"Viral Immunol."},{"key":"BFnrneurol2012258_CR40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0168-1702(89)90039-7","volume":"12","author":"RH Kimberlin","year":"1989","unstructured":"Kimberlin, R. H. & Walker, C. A. The role of the spleen in the neuroinvasion of scrapie in mice. Virus Res. 12, 201\u2013211 (1989).","journal-title":"Virus Res."},{"key":"BFnrneurol2012258_CR41","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1126\/science.288.5469.1257","volume":"288","author":"F Montrasio","year":"2000","unstructured":"Montrasio, F. et al. Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288, 1257\u20131259 (2000).","journal-title":"Science"},{"key":"BFnrneurol2012258_CR42","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/37789","volume":"390","author":"MA Klein","year":"1997","unstructured":"Klein, M. A. et al. A crucial role for B cells in neuroinvasive scrapie. Nature 390, 687\u2013690 (1997).","journal-title":"Nature"},{"key":"BFnrneurol2012258_CR43","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/4022","volume":"4","author":"MA Klein","year":"1998","unstructured":"Klein, M. A. et al. PrP expression in B lymphocytes is not required for prion neuroinvasion. Nat. Med. 4, 1429\u20131433 (1998).","journal-title":"Nat. Med."},{"key":"BFnrneurol2012258_CR44","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1128\/JVI.74.7.3338-3344.2000","volume":"74","author":"NA Mabbott","year":"2000","unstructured":"Mabbott, N. A. et al. Tumor necrosis factor alpha-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie. J. Virol. 74, 3338\u20133344 (2000).","journal-title":"J. Virol."},{"key":"BFnrneurol2012258_CR45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/bmb\/66.1.141","volume":"66","author":"A Aguzzi","year":"2003","unstructured":"Aguzzi, A. et al. Immune system and peripheral nerves in propagation of prions to CNS. Br. Med. Bull. 66, 141\u2013159 (2003).","journal-title":"Br. Med. Bull."},{"key":"BFnrneurol2012258_CR46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0896-6273(01)00385-3","volume":"31","author":"P Nicotera","year":"2001","unstructured":"Nicotera, P. A route for prion neuroinvasion. Neuron 31, 345\u2013348 (2001).","journal-title":"Neuron"},{"key":"BFnrneurol2012258_CR47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0896-6273(01)00331-2","volume":"31","author":"M Glatzel","year":"2001","unstructured":"Glatzel, M., Heppner, F. L., Albers, K. M. & Aguzzi, A. Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron 31, 25\u201334 (2001).","journal-title":"Neuron"},{"key":"BFnrneurol2012258_CR48","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nature02072","volume":"425","author":"M Prinz","year":"2003","unstructured":"Prinz, M. et al. Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature 425, 957\u2013962 (2003).","journal-title":"Nature"},{"key":"BFnrneurol2012258_CR49","doi-asserted-by":"crossref","first-page":"e1002651","DOI":"10.1371\/journal.ppat.1002651","volume":"8","author":"A Aguzzi","year":"2012","unstructured":"Aguzzi, A. & Zhu, C. Five questions on prion diseases. PLoS Pathog. 8, e1002651 (2012).","journal-title":"PLoS Pathog."},{"key":"BFnrneurol2012258_CR50","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00249-007-0246-z","volume":"37","author":"LJ Vella","year":"2008","unstructured":"Vella, L. J., Sharples, R. A., Nisbet, R. M., Cappai, R. & Hill, A. F. The role of exosomes in the processing of proteins associated with neurodegenerative diseases. Eur. Biophys. J. 37, 323\u2013332 (2008).","journal-title":"Eur. Biophys. J."},{"key":"BFnrneurol2012258_CR51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-59745-234-2_5","volume":"459","author":"LJ Vella","year":"2008","unstructured":"Vella, L. J. & Hill, A. F. Generation of cell lines propagating infectious prions and the isolation and characterization of cell-derived exosomes. Methods Mol. Biol. 459, 69\u201382 (2008).","journal-title":"Methods Mol. Biol."},{"key":"BFnrneurol2012258_CR52","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1038\/sj.emboj.7601162","volume":"25","author":"P Leblanc","year":"2006","unstructured":"Leblanc, P. et al. Retrovirus infection strongly enhances scrapie infectivity release in cell culture. EMBO J. 25, 2674\u20132685 (2006).","journal-title":"EMBO J."},{"key":"BFnrneurol2012258_CR53","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1042\/BC20080025","volume":"100","author":"S Alais","year":"2008","unstructured":"Alais, S. et al. Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles. Biol. Cell 100, 603\u2013615 (2008).","journal-title":"Biol. Cell"},{"key":"BFnrneurol2012258_CR54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","volume":"400","author":"D Schenk","year":"1999","unstructured":"Schenk, D. et al. Immunization with amyloid-\u03b2 attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173\u2013177 (1999).","journal-title":"Nature"},{"key":"BFnrneurol2012258_CR55","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/35050116","volume":"408","author":"D Morgan","year":"2000","unstructured":"Morgan, D. et al. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408, 982\u2013985 (2000).","journal-title":"Nature"},{"key":"BFnrneurol2012258_CR56","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/78682","volume":"6","author":"F Bard","year":"2000","unstructured":"Bard, F. et al. Peripherally administered antibodies against amyloid \u03b2-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6, 916\u2013919 (2000).","journal-title":"Nat. Med."},{"key":"BFnrneurol2012258_CR57","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4049\/jimmunol.111.5.1407","volume":"111","author":"DD Porter","year":"1973","unstructured":"Porter, D. D., Porter, H. G. & Cox, N. A. Failure to demonstrate a humoral immune response to scrapie infection in mice. J. Immunol. 111, 1407\u20131410 (1973).","journal-title":"J. Immunol."},{"key":"BFnrneurol2012258_CR58","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0165-5728(82)90022-4","volume":"3","author":"KC Kasper","year":"1982","unstructured":"Kasper, K. C., Stites, D. P., Bowman, K. A., Panitch, H. & Prusiner, S. B. Immunological studies of scrapie infection. J. Neuroimmunol. 3, 187\u2013201 (1982).","journal-title":"J. Neuroimmunol."},{"key":"BFnrneurol2012258_CR59","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1189\/jlb.72.6.1075","volume":"72","author":"P Aucouturier","year":"2002","unstructured":"Aucouturier, P. & Carnaud, C. The immune system and prion diseases: a relationship of complicity and blindness. J. Leukoc. Biol. 72, 1075\u20131083 (2002).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneurol2012258_CR60","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1189\/jlb.1106665","volume":"81","author":"DS Spinner","year":"2007","unstructured":"Spinner, D. S. et al. CpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein PrPSc in mice immunized with 139A scrapie-associated fibrils. J. Leukoc. Biol. 81, 1374\u20131385 (2007).","journal-title":"J. Leukoc. Biol."},{"issue":"Suppl. 2","key":"BFnrneurol2012258_CR61","doi-asserted-by":"crossref","first-page":"14670","DOI":"10.1073\/pnas.0404772101","volume":"101","author":"M Polymenidou","year":"2004","unstructured":"Polymenidou, M. et al. Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection. Proc. Natl Acad. Sci. USA 101 (Suppl. 2), 14670\u201314676 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2012258_CR62","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/BF03401656","volume":"2","author":"S Krasemann","year":"1996","unstructured":"Krasemann, S., Groschup, M. H., Harmeyer, S., Hunsmann, G. & Bodemer, W. Generation of monoclonal antibodies against human prion proteins in PrP0\/0 mice. Mol. Med. 2, 725\u2013734 (1996).","journal-title":"Mol. Med."},{"key":"BFnrneurol2012258_CR63","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1006\/bbrc.1999.1730","volume":"265","author":"S Demart","year":"1999","unstructured":"Demart, S. et al. New insight into abnormal prion protein using monoclonal antibodies. Biochem. Biophys. Res. Commun. 265, 652\u2013657 (1999).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrneurol2012258_CR64","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1365-2249.2003.02242.x","volume":"133","author":"J Bainbridge","year":"2003","unstructured":"Bainbridge, J. & Walker, B. Cell mediated immune responses against human prion protein. Clin. Exp. Immunol. 133, 310\u2013317 (2003).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrneurol2012258_CR65","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1189\/jlb.1203656","volume":"76","author":"S Gregoire","year":"2004","unstructured":"Gregoire, S. et al. Identification of two immunogenic domains of the prion protein--PrP--which activate class II-restricted T cells and elicit antibody responses against the native molecule. J. Leukoc. Biol. 76, 125\u2013134 (2004).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneurol2012258_CR66","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.virol.2003.10.026","volume":"320","author":"CL Kim","year":"2004","unstructured":"Kim, C. L. et al. Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies. Virology 320, 40\u201351 (2004).","journal-title":"Virology"},{"key":"BFnrneurol2012258_CR67","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.4049\/jimmunol.174.6.3256","volume":"174","author":"A Khalili-Shirazi","year":"2005","unstructured":"Khalili-Shirazi, A. et al. Protein conformation significantly influences immune responses to prion protein. J. Immunol. 174, 3256\u20133263 (2005).","journal-title":"J. Immunol."},{"key":"BFnrneurol2012258_CR68","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/153685903322328992","volume":"22","author":"N Nakamura","year":"2003","unstructured":"Nakamura, N. et al. Generation of antibodies against prion protein by scrapie-infected cell immunization of PrP0 mice. Hybrid Hybridomics 22, 263\u2013266 (2003).","journal-title":"Hybrid Hybridomics"},{"key":"BFnrneurol2012258_CR69","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/brain\/awl150","volume":"129","author":"CR Trevitt","year":"2006","unstructured":"Trevitt, C. R. & Collinge, J. A systematic review of prion therapeutics in experimental models. Brain 129, 2241\u20132265 (2006).","journal-title":"Brain"},{"key":"BFnrneurol2012258_CR70","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00063030-200822010-00005","volume":"22","author":"A Muller-Schiffmann","year":"2008","unstructured":"Muller-Schiffmann, A. & Korth, C. Vaccine approaches to prevent and treat prion infection: progress and challenges. BioDrugs 22, 45\u201352 (2008).","journal-title":"BioDrugs"},{"key":"BFnrneurol2012258_CR71","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jneuroim.2003.08.036","volume":"144","author":"M Arbel","year":"2003","unstructured":"Arbel, M., Lavie, V. & Solomon, B. Generation of antibodies against prion protein in wild-type mice via helix 1 peptide immunization. J. Neuroimmunol. 144, 38\u201345 (2003).","journal-title":"J. Neuroimmunol."},{"key":"BFnrneurol2012258_CR72","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2249.2004.02538.x","volume":"137","author":"J Bainbridge","year":"2004","unstructured":"Bainbridge, J., Jones, N. & Walker, B. Multiple antigenic peptides facilitate generation of anti-prion antibodies. Clin. Exp. Immunol. 137, 298\u2013304 (2004).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrneurol2012258_CR73","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/1521-4141(200108)31:8<2338::AID-IMMU2338>3.0.CO;2-V","volume":"31","author":"L Souan","year":"2001","unstructured":"Souan, L. et al. Modulation of proteinase-K resistant prion protein by prion peptide immunization. Eur. J. Immunol. 31, 2338\u20132346 (2001).","journal-title":"Eur. J. Immunol."},{"key":"BFnrneurol2012258_CR74","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(03)00907-8","volume":"350","author":"A Schwarz","year":"2003","unstructured":"Schwarz, A. et al. Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent. Neurosci. Lett. 350, 187\u2013189 (2003).","journal-title":"Neurosci. Lett."},{"key":"BFnrneurol2012258_CR75","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1099\/vir.0.013417-0","volume":"91","author":"V Bachy","year":"2010","unstructured":"Bachy, V. et al. Mouse vaccination with dendritic cells loaded with prion protein peptides overcomes tolerance and delays scrapie. J. Gen. Virol. 91, 809\u2013820 (2010).","journal-title":"J. Gen. Virol."},{"key":"BFnrneurol2012258_CR76","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-5728(02)00316-8","volume":"132","author":"MF Koller","year":"2002","unstructured":"Koller, M. F., Grau, T. & Christen, P. Induction of antibodies against murine full-length prion protein in wild-type mice. J. Neuroimmunol. 132, 113\u2013116 (2002).","journal-title":"J. Neuroimmunol."},{"key":"BFnrneurol2012258_CR77","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-9440(10)64151-X","volume":"161","author":"EM Sigurdsson","year":"2002","unstructured":"Sigurdsson, E. M. et al. Immunization delays the onset of prion disease in mice. Am. J. Pathol. 161, 13\u201317 (2002).","journal-title":"Am. J. Pathol."},{"key":"BFnrneurol2012258_CR78","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.vaccine.2006.09.078","volume":"25","author":"D Ishibashi","year":"2007","unstructured":"Ishibashi, D. et al. Immunization with recombinant bovine but not mouse prion protein delays the onset of disease in mice inoculated with a mouse-adapted prion. Vaccine 25, 985\u2013992 (2007).","journal-title":"Vaccine"},{"key":"BFnrneurol2012258_CR79","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1099\/vir.0.005041-0","volume":"90","author":"M Tayebi","year":"2009","unstructured":"Tayebi, M., Collinge, J. & Hawke, S. Unswitched immunoglobulin M response prolongs mouse survival in prion disease. J. Gen. Virol. 90, 777\u2013782 (2009).","journal-title":"J. Gen. Virol."},{"key":"BFnrneurol2012258_CR80","doi-asserted-by":"crossref","first-page":"9321","DOI":"10.1016\/j.vaccine.2011.10.017","volume":"29","author":"D Ishibashi","year":"2011","unstructured":"Ishibashi, D. et al. Antigenic mimicry-mediated anti-prion effects induced by bacterial enzyme succinylarginine dihydrolase in mice. Vaccine 29, 9321\u20139328 (2011).","journal-title":"Vaccine"},{"key":"BFnrneurol2012258_CR81","doi-asserted-by":"crossref","first-page":"e4917","DOI":"10.1371\/journal.pone.0004917","volume":"4","author":"MB Rosset","year":"2009","unstructured":"Rosset, M. B. et al. Dendritic cell-mediated-immunization with xenogenic PrP and adenoviral vectors breaks tolerance and prolongs mice survival against experimental scrapie. PLoS ONE 4, e4917 (2009).","journal-title":"PLoS ONE"},{"key":"BFnrneurol2012258_CR82","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.vaccine.2005.12.051","volume":"24","author":"S Bade","year":"2006","unstructured":"Bade, S., Baier, M., Boetel, T. & Frey, A. Intranasal immunization of Balb\/c mice against prion protein attenuates orally acquired transmissible spongiform encephalopathy. Vaccine 24, 1242\u20131253 (2006).","journal-title":"Vaccine"},{"key":"BFnrneurol2012258_CR83","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.neuroscience.2008.02.051","volume":"153","author":"F Goni","year":"2008","unstructured":"Goni, F. et al. High titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated mice. Neuroscience 153, 679\u2013686 (2008).","journal-title":"Neuroscience"},{"key":"BFnrneurol2012258_CR84","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/01.WNL.0000148604.77591.67","volume":"64","author":"AJ Bayer","year":"2005","unstructured":"Bayer, A. J. et al. Evaluation of the safety and immunogenicity of synthetic A\u03b242 (AN1792) in patients with AD. Neurology 64, 94\u2013101 (2005).","journal-title":"Neurology"},{"key":"BFnrneurol2012258_CR85","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nrn938","volume":"3","author":"D Schenk","year":"2002","unstructured":"Schenk, D. Amyloid-\u03b2 immunotherapy for Alzheimer's disease: the end of the beginning. Nat. Rev. Neurosci. 3, 824\u2013828 (2002).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnrneurol2012258_CR86","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1126\/science.1094273","volume":"303","author":"L Solforosi","year":"2004","unstructured":"Solforosi, L. et al. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303, 1514\u20131516 (2004).","journal-title":"Science"},{"key":"BFnrneurol2012258_CR87","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1126\/science.1215579","volume":"335","author":"PC Klohn","year":"2012","unstructured":"Klohn, P. C. et al. PrP antibodies do not trigger mouse hippocampal neuron apoptosis. Science 335, 52 (2012).","journal-title":"Science"},{"key":"BFnrneurol2012258_CR88","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1126\/science.1063093","volume":"294","author":"FL Heppner","year":"2001","unstructured":"Heppner, F. L. et al. Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science 294, 178\u2013182 (2001).","journal-title":"Science"},{"key":"BFnrneurol2012258_CR89","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0304-3940(02)01192-8","volume":"336","author":"EM Sigurdsson","year":"2003","unstructured":"Sigurdsson, E. M. et al. Anti-prion antibodies for prophylaxis following prion exposure in mice. Neurosci. Lett. 336, 185\u2013187 (2003).","journal-title":"Neurosci. Lett."},{"key":"BFnrneurol2012258_CR90","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nature01457","volume":"422","author":"AR White","year":"2003","unstructured":"White, A. R. et al. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422, 80\u201383 (2003).","journal-title":"Nature"},{"key":"BFnrneurol2012258_CR91","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.nbd.2009.01.013","volume":"34","author":"MJ Sadowski","year":"2009","unstructured":"Sadowski, M. J. et al. Anti-PrP Mab 6D11 suppresses PrPSc replication in prion infected myeloid precursor line FDC-P1\/22L and in the lymphoreticular system in vivo. Neurobiol. Dis. 34, 267\u2013278 (2009).","journal-title":"Neurobiol. Dis."},{"key":"BFnrneurol2012258_CR92","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4161\/pri.1.3.5273","volume":"1","author":"C Zuber","year":"2007","unstructured":"Zuber, C. et al. Anti-LRP\/LR antibody W3 hampers peripheral PrPSc propagation in scrapie infected mice. Prion 1, 207\u2013212 (2007).","journal-title":"Prion"},{"key":"BFnrneurol2012258_CR93","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/505914","volume":"194","author":"S Gauczynski","year":"2006","unstructured":"Gauczynski, S. et al. The 37-kDa\/67-kDa laminin receptor acts as a receptor for infectious prions and is inhibited by polysulfated glycanes. J. Infect. Dis. 194, 702\u2013709 (2006).","journal-title":"J. Infect. Dis."},{"key":"BFnrneurol2012258_CR94","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1093\/emboj\/20.21.5863","volume":"20","author":"S Gauczynski","year":"2001","unstructured":"Gauczynski, S. et al. The 37-kDa\/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J. 20, 5863\u20135875 (2001).","journal-title":"EMBO J."},{"key":"BFnrneurol2012258_CR95","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.embor.embor768","volume":"4","author":"C Leucht","year":"2003","unstructured":"Leucht, C. et al. The 37 kDa\/67 kDa laminin receptor is required for PrPSc propagation in scrapie-infected neuronal cells. EMBO Rep. 4, 290\u2013295 (2003).","journal-title":"EMBO Rep."},{"key":"BFnrneurol2012258_CR96","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.molimm.2007.04.030","volume":"45","author":"C Zuber","year":"2008","unstructured":"Zuber, C. et al. Single chain Fv antibodies directed against the 37 kDa\/67 kDa laminin receptor as therapeutic tools in prion diseases. Mol. Immunol. 45, 144\u2013151 (2008).","journal-title":"Mol. Immunol."},{"key":"BFnrneurol2012258_CR97","doi-asserted-by":"crossref","first-page":"12858","DOI":"10.1074\/jbc.M111.255836","volume":"287","author":"X Wei","year":"2012","unstructured":"Wei, X. et al. Human anti-prion antibodies block prion peptide fibril formation and neurotoxicity. J. Biol. Chem. 287, 12858\u201312866 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol2012258_CR98","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ana.21475","volume":"65","author":"A Kellner","year":"2009","unstructured":"Kellner, A. et al. Autoantibodies against \u03b2-amyloid are common in Alzheimer's disease and control plaque burden. Ann. Neurol. 65, 24\u201331 (2009).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2012258_CR99","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1136\/jnnp.2003.033399","volume":"75","author":"RC Dodel","year":"2004","unstructured":"Dodel, R. C. et al. Intravenous immunoglobulins containing antibodies against \u03b2-amyloid for the treatment of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 75, 1472\u20131474 (2004).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol2012258_CR100","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.neurobiolaging.2007.12.021","volume":"30","author":"NR Relkin","year":"2009","unstructured":"Relkin, N. R. et al. 18-month study of intravenous immunoglobulin for treatment of mild Alzheimer disease. Neurobiol. Aging 30, 1728\u20131736 (2009).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2012258_CR101","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00418-010-0687-9","volume":"133","author":"G Dorban","year":"2010","unstructured":"Dorban, G., Defaweux, V., Heinen, E. & Antoine, N. Spreading of prions from the immune to the peripheral nervous system: a potential implication of dendritic cells. Histochem. Cell Biol. 133, 493\u2013504 (2010).","journal-title":"Histochem. Cell Biol."},{"key":"BFnrneurol2012258_CR102","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/brain\/awg191","volume":"126","author":"Y Du","year":"2003","unstructured":"Du, Y. et al. Human anti-\u03b2-amyloid antibodies block \u03b2-amyloid fibril formation and prevent \u03b2-amyloid-induced neurotoxicity. Brain 126, 1935\u20131939 (2003).","journal-title":"Brain"},{"key":"BFnrneurol2012258_CR103","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1523\/JNEUROSCI.4401-10.2011","volume":"31","author":"R Dodel","year":"2011","unstructured":"Dodel, R. et al. Naturally occurring autoantibodies against \u03b2-amyloid: investigating their role in transgenic animal and in vitro models of Alzheimer's disease. J. Neurosci. 31, 5847\u20135854 (2011).","journal-title":"J. Neurosci."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2012.258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2012.258","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2012.258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T21:35:52Z","timestamp":1687901752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2012.258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,18]]},"references-count":103,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["BFnrneurol2012258"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2012.258","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,18]]}}}